Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Europe

Daily deal net: May 7, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
BeLab1407 brings $20m to UK universities
Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.
Daily deal net: May 5, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mogrify magnifies series A
Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.
Inivata inspires $390m acquisition
NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.
O’Brien to lead Cambridge Enterprise
Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.
Daily deal net: April 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Other News

Vaccitech injects shares into public market
Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.
Adcendo accepts series A funding
Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.
The time is now for northern England
Historically left behind by their peers in the golden triangle, universities in the north are stepping up with their own funds, accelerators and collaborations.
How Evox is engineering a new class of therapeutics
Chief executive Antonin de Fougerolles talks about Evox’s journey to commercialising a new modality that could prove truly transformational.
CytoSeek chases cell therapy’s holy grail
The University of Bristol spinout is working on adapting cell therapies to solid tumours.
Exscientia erects $225m series D
Less than two months after closing a $100m series C round, the Durham spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

Editor's Picks

O’Brien to lead Cambridge Enterprise
Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.
The time is now for northern England
Historically left behind by their peers in the golden triangle, universities in the north are stepping up with their own funds, accelerators and collaborations.
SETsquared portfolio to pitch at GCV Digital Forum
Four of the incubator’s portfolio companies will pitch to investors at the GCV Digital Forum 3.0 following the success of similar competitions at our previous events.
Raven reaches for next adventure
Tony Raven, CEO of Cambridge Enterprise and a GUV Lifetime Achievement awardee, will step down by the end of next year.
test reg

Login